$2.02
-0.05-2.41%
Pre-Market: 6:19 PM EDT
Comments
Loading...
Allogene Therapeutics (NASDAQ:ALLO) Stock, Earnings Estimates, EPS, And Revenue
Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$12.1K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$43K
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Allogene Therapeutics (ALLO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.32 | $-0.33 | 3.03 % |
| Jun 2024 | 2024-08-07 | $-0.35 | $-0.35 | 0.00 % |
| Mar 2024 | 2024-05-13 | $-0.38 | $-0.41 | 7.32 % |
| Dec 2023 | 2024-03-14 | $-0.43 | $-0.45 | 4.44 % |
Allogene Therapeutics (ALLO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $0 | $10.00K | -100.0 % |
| Jun 2024 | 2024-08-07 | $0 | $20.00K | -100.0 % |
| Mar 2024 | 2024-05-13 | $22.00K | $10.00K | 120.0 % |
| Dec 2023 | 2024-03-14 | $21.00K | $20.00K | 5.00 % |
FAQ
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics (ALLO) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Allogene Therapeutics (NASDAQ:ALLO)?
The Actual EPS was $-0.32, which beat the estimate of $-0.33.
What were Allogene Therapeutics’s (NASDAQ:ALLO) revenues?
The Actual Revenue was $0K, which missed the estimate of $10K.
Browse earnings estimates, EPS, and revenue on all stocks.